Climb Bio CLYM Balance Sheet (2020-2026)

NASDAQ CLYM
$15.52 +0.93 (+6.37%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Climb Bio Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Climb Bio reported total assets of $246.29M and total liabilities of $6.75M for the quarter ended Jun 2026, up 28.0% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Receivables - AccuredAcc. Int. Receivables
0.30M0.50M0.30M0.20M0.20M0.10M0.20M0.10M0.30M0.40M0.99M0.80M1.37M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
145.23M145.03M134.86M116.03M116.39M107.45M100.52M99.75M100.39M102.88M105.03M223.14M214.53M87.23M197.00M22.68M25.80M35.69M8.36M44.11M
Prepaid Assets
12.61M11.77M9.34M10.12M10.55M10.83M10.80M11.61M5.00M3.46M4.19M2.86M4.26M3.95M2.22M2.68M4.06M4.77M3.84M3.51M
Current Assets
158.63M148.25M133.28M133.08M133.17M134.39M120.17M114.24M112.43M110.25M109.22M226.00M197.61M154.87M100.28M87.38M90.96M105.85M113.40M186.64M
Non-Current Assets
Property, Plant & Equipment (Net)
0.20M0.31M0.32M0.29M0.25M0.69M
Long-Term Investments
23.62M24.92M25.91M11.70M6.96M24.58M61.61M99.78M102.70M88.93M59.57M36.74M56.10M
Other Non-Current Assets
1.05M0.85M2.42M4.63M0.56M0.46M1.25M1.66M0.60M0.11M0.62M0.70M0.36M0.02M0.23M1.37M1.53M1.53M1.53M1.65M
Non-Current Assets
23.62M24.99M29.14M17.03M7.69M0.60M1.91M2.03M0.30M0.21M0.11M0.02M24.59M62.31M100.46M105.00M91.34M61.90M38.97M59.66M
Assets
182.25M173.24M162.42M150.10M140.86M134.99M122.08M116.27M112.73M110.47M109.33M226.02M222.20M217.19M200.74M192.39M182.30M167.74M152.37M246.29M
Liabilities
Current Liabilities
Accounts Payables
2.58M1.40M0.85M1.06M1.49M0.75M0.86M0.88M0.74M0.07M0.09M0.51M0.29M0.70M0.78M0.95M0.48M2.27M0.86M1.13M
Payables
2.58M1.40M0.85M1.06M1.49M0.75M0.86M0.88M0.74M0.07M0.09M0.51M0.29M0.70M0.78M0.95M0.48M2.27M0.86M1.13M
Accumulated Expenses
2.98M4.63M5.48M6.07M4.43M5.05M3.59M2.25M1.76M2.43M2.64M3.03M3.04M4.07M6.10M5.04M4.24M4.46M2.95M4.30M
Other Accumulated Expenses
0.24M0.14M0.30M1.28M1.18M0.09M1.00M0.04M0.08M0.06M0.11M0.29M
Short term Debt
0.02M
Current Leases
0.46M0.44M0.35M0.30M0.46M0.48M0.40M0.33M0.23M0.10M0.06M0.16M0.15M0.22M0.23M0.26M0.26M0.50M
Total Current Liabilities
5.59M6.03M6.90M7.61M6.28M6.10M4.92M3.62M2.90M2.83M2.95M3.74M3.42M4.93M7.04M6.21M4.95M6.98M4.07M5.93M
Non-Current Liabilities
Preferred Stock Liabilities
Operating Leases
0.38M0.69M0.57M0.18M0.22M0.10M0.06M0.01M0.38M0.32M0.42M0.35M0.28M0.22M0.81M
Non-Current Deferred Tax Liability
-0.01M0.14M0.09M
Other Non-Current Liabilities
0.01M0.09M0.06M0.03M0.02M
Total Non-Current Liabilities
6.03M7.28M7.87M6.50M6.28M5.14M3.72M2.96M2.85M2.95M3.74M3.42M5.31M
Total Liabilities
5.59M6.04M7.28M7.87M6.50M6.28M5.22M3.77M2.99M2.87M2.95M3.74M3.42M5.31M7.36M6.62M5.30M7.27M4.29M6.75M
Shareholder's Equity
Total Debt
0.02M
Common Equity
176.66M167.20M155.14M142.24M134.36M128.72M116.86M112.50M109.74M107.60M106.38M222.28M218.78M211.88M193.38M185.76M177.00M160.47M148.09M239.55M
Liabilities and Shareholders Equity
182.25M173.24M162.42M150.10M140.86M134.99M122.08M116.27M112.73M110.47M109.33M226.02M222.20M217.19M200.74M192.39M182.30M167.74M152.37M246.29M
Retained Earnings
-65.10M-75.62M-88.82M-103.42M-113.10M-120.86M-143.20M-148.40M-152.34M-155.98M-157.70M-212.60M-221.50M-229.88M-250.70M-259.32M-272.21M-289.73M-303.45M-316.95M
Preferred Shares
Treasury Shares